![Jon Ellis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jon Ellis
Direttore/Membro del Consiglio presso Orchard Therapeutics (Europe) Ltd.
Posizioni attive di Jon Ellis
Società | Posizione | Inizio | Fine |
---|---|---|---|
Orchard Therapeutics (Europe) Ltd.
![]() Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | 02/08/2018 | - |
Storia della carriera di Jon Ellis
Precedenti posizioni note di Jon Ellis
Società | Posizione | Inizio | Fine |
---|---|---|---|
GSK PLC | Direttore Tecnico/Scientifico/R&S | 01/01/2001 | 01/08/2022 |
ORCHARD THERAPEUTICS PLC | Direttore/Membro del Consiglio | 01/08/2018 | 16/06/2021 |
Independent Dir/Board Member | 01/08/2018 | 16/06/2021 |
Formazione di Jon Ellis
University of Cambridge | Doctorate Degree |
Henley Management College | Masters Business Admin |
Magdalene College | Graduate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 7 |
Posizioni
Director/Board Member | 2 |
Doctorate Degree | 1 |
Masters Business Admin | 1 |
Settori
Consumer Services | 4 |
Health Technology | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
GSK PLC | Health Technology |
Aziende private | 2 |
---|---|
Orchard Therapeutics (Europe) Ltd.
![]() Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
Orchard Therapeutics Plc
![]() Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Jon Ellis
- Esperienza